Oct. 20 (Bloomberg) -- Omega Pharma NV spent almost 3.41 million euros buying back an additional 99,242 own shares in on- and off-market transaction in the period from Oct. 12 through Oct. 20 and now holds 13.8 percent of its outstanding shares, according to an e-mailed statement.

To contact the editor responsible for this story: John Martens at jmartens1@bloomberg.net